Juliet M Taylor

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 7

Top Topics

Traumatic Brain Injury

Inflammatory Response

Top Venues

Scientific reports

British journal of pharmacology

Journal of neuroinflammation

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Amelia L Fryer, Amar Abdullah, Frank Mobilio, Andrew I Jobling, Zachery Moore, Michael de Veer, Gang Zheng, Bruce X Wong, Juliet M Taylor, Peter J Crack
Pharmacological inhibition of STING reduces neuroinflammation-mediated damage post-traumatic brain injury. British journal of pharmacology 181 (17) (2024)
Amelia L Fryer, Amar Abdullah, Frank Mobilio, Andrew I Jobling, Zachery Moore, Michael de Veer, Gang Zheng, Bruce X Wong, Juliet M Taylor, Peter J Crack
Pharmacological inhibition of STING reduces neuroinflammation-mediated damage post-traumatic brain injury. British journal of pharmacology (2024)
Amar Abdullah, Frank Mobilio, Peter J Crack, Juliet M Taylor
STING-Mediated Autophagy Is Protective against H2O2-Induced Cell Death. International journal of molecular sciences 21 (19) (2020)
Zachery Moore, Frank Mobilio, Frederick R Walker, Juliet M Taylor, Peter J Crack
Abrogation of type-I interferon signalling alters the microglial response to Aβ1-42. Scientific reports 10 (1) (2020)
Amar Abdullah, Moses Zhang, Tony Frugier, Sammy Bedoui, Juliet M Taylor, Peter J Crack
STING-mediated type-I interferons contribute to the neuroinflammatory process and detrimental effects following traumatic brain injury. Journal of neuroinflammation 15 (1) (2018)
Sarah E M Stephenson, Timothy D Aumann, Juliet M Taylor, Jessica R Riseley, Ruili Li, Jeffrey R Mann, Doris Tomas, Paul J Lockhart
Generation and characterisation of a parkin-Pacrg knockout mouse line and a Pacrg knockout mouse line. Scientific reports 8 (1) (2018)
Bevan S Main, Moses Zhang, Kate M Brody, Scott Ayton, Tony Frugier, David Steer, David Finkelstein, Peter J Crack, Juliet M Taylor
Type-1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson's disease. Glia 64 (9) (2016)